Isaridin E Attenuates Ischemic Brain Injury in Mice by Concurrently Reducing Platelet Hyperactivity and Microglial Neuroinflammation Associated with LRP1
Marine Drugs · 2026
DOI: 10.3390/md24090328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2026. Verfasst von Yu-Chen Mi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China. Hauptthemen laut MEDLINE: Microglia, Low Density Lipoprotein Receptor-Related Protein-1, Neuroprotective Agents, Blood Platelets. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Science and Technology Program of Guangzhou City.
Abstract (Originalsprache)
Isaridin E (ISE), a marine-derived fungal cyclodepsipeptide, possesses antiplatelet activity in vitro and antithrombotic efficacy in a FeCl3-induced carotid artery thrombosis mouse model without prolonging bleeding time. In this study, we investigated the antiplatelet and neuroprotective effects of prophylactic and therapeutic administration of ISE in a transient middle cerebral artery occlusion (tMCAO) mouse model. We found that both prophylactic administration (50 and 100 mg/kg) and therapeutic administration (50 mg/kg) of ISE significantly reduced cerebral infarct volume, alleviated neurological deficits, and attenuated neuronal injury. Furthermore, therapeutic administration of ISE suppressed platelet hyperactivity, as evidenced by reduced P-selectin expression, downregulated platelet secretion-related proteins (SNAP23, VAMP8), and decreased plasma levels of platelet-derived pro-inflammatory cytokines (IL-1β, PF4, and CCL5). Moreover, ISE attenuated microglial inflammatory activation in the peri-infarct region in vivo. Mechanistically, in vitro studies revealed that this effect may be mediated through the LRP1/IκB/NF-κB signaling pathway. In conclusion, these results suggest that ISE protects mice against ischemic stroke by concurrently suppressing platelet hyperactivity and LRP1-associated microglial neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
- School of Marine Sciences, Sun Yat-sen University, Zhuhai 519082, China.
- Southern Marine Sciences and Engineering Guangdong Laboratory (Zhuhai), Zhuhai 519000, China.
- Department of Pharmacy, The Second Clinical College, Guangzhou Medical University, Guangzhou 510261, China.
ORCID-Profile: Lan Liu, Guan-Lei Wang
Förderung
- Natural Science Foundation of Guangdong Province
- Science and Technology Program of Guangzhou City
Zitieren
APA
Mi, Y. C., Li, Z. C., Jiang, Q. Q., Liu, L., Chen, S. H., Pan, N., & Wang, G. L. (2026). Isaridin E Attenuates Ischemic Brain Injury in Mice by Concurrently Reducing Platelet Hyperactivity and Microglial Neuroinflammation Associated with LRP1. Marine Drugs. https://doi.org/10.3390/md24090328
Vancouver
Mi YC, Li ZC, Jiang QQ, Liu L, Chen SH, Pan N, et al. Isaridin E Attenuates Ischemic Brain Injury in Mice by Concurrently Reducing Platelet Hyperactivity and Microglial Neuroinflammation Associated with LRP1. Marine Drugs. 2026. doi:10.3390/md24090328
BibTeX
@article{Mi2026,
author = {Mi, Yu-Chen and Li, Zi-Cheng and Jiang, Qi-Qi and Liu, Lan and Chen, Sen-Hua and Pan, Ni and Wang, Guan-Lei},
title = {Isaridin E Attenuates Ischemic Brain Injury in Mice by Concurrently Reducing Platelet Hyperactivity and Microglial Neuroinflammation Associated with LRP1},
journal = {Marine Drugs},
year = {2026},
doi = {10.3390/md24090328}
}
EUVIMED